VivoSim Labs (VIVS) FCF Margin (QoQ) (2011 - 2026)
Powered by 
Analysis
VivoSim Labs (VIVS) FCF Margin (QoQ) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.24 Mn |
| Mar 31, 2026 | 320,942.00 |
| Dec 31, 2025 | -28,407.00 |
| Sep 30, 2025 | 215,579.00 |
| Jun 30, 2025 | -665,845.00 |
| Mar 31, 2025 | 351,397.00 |
| Dec 31, 2024 | 134,583.00 |
| Sep 30, 2024 | -120,128.00 |
| Jun 30, 2024 | 156,163.00 |
| Mar 31, 2024 | 6.12 Mn |
| Jun 30, 2023 | -407,973.00 |
| Mar 31, 2023 | -66,664.00 |
| Dec 31, 2022 | 67,880.00 |
| Dec 31, 2019 | 22,347.00 |
| Sep 30, 2019 | 46,937.00 |
| Jun 30, 2019 | -13,568.00 |
| Mar 31, 2019 | -24,214.00 |
| Dec 31, 2018 | -5,095.00 |
| Sep 30, 2018 | 55,946.00 |
| Jun 30, 2018 | -49,907.00 |